EXOSC5 anticorps (N-Term)
Aperçu rapide pour EXOSC5 anticorps (N-Term) (ABIN5672011)
Antigène
Voir toutes EXOSC5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- CSLRHFACEQ NLLSRPDGSA SFLQGDTSVL AGVYGPAEVK VSKEIFNKAT
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 91%
-
Attributs du produit
- This is a rabbit polyclonal antibody against EXOS5. It was validated on Western Blot.
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N-terminal region of Human EXOS5
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EXOSC5 (Exosome Component 5 (EXOSC5))
-
Autre désignation
- EXOS5
-
Sujet
-
EXOS5 is a non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation .
Alias Symbols: EXOSC5, CML28, RRP46,
Protein Interaction Partner: DOCK8, TRIM54, EXOSC1, FCHO1, IKZF3, EXOSC8, CALCOCO2, TNFAIP1, REL, KRT13, GOLGA2, BIRC2, UBC, rev, ZNF558, CDK5RAP1, EXOSC3, SRPK3, POLR2L, EXOSC10, PA2G4, LIPG, AICDA, DHRS2, EXOSC4, EXOSC2, PSIP1, EXOSC9, DIS3L, DIS3, CUL3, MEPCE, CDK9, SKIV2L2, EXOSC
Protein Size: 235 -
ID gène
- 56915
-
NCBI Accession
- NP_064543
-
UniProt
- Q9NQT4
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-